Celestoderm-V cream with Garamycin

Krajina: Arménsko

Jazyk: angličtina

Zdroj: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Aktívna zložka:

betamethasone (betamethasone 17-valerate), gentamicin (gentamicin sulfate)

Dostupné z:

Schering-Plough Labo N.V.

INN (Medzinárodný Name):

betamethasone (betamethasone 17-valerate), gentamicin (gentamicin sulfate)

Dávkovanie:

1mg/g+1mg/g

Forma lieku:

cream

Typ predpisu:

Prescription

Súhrn charakteristických

1
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
CELESTODERM-V
®
WITH GARAMYCIN
®
1 mg/g + 1 mg/g, Cream
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substances: gentamicin sulfate, betamethasone valerate (Ph.
Eur.)
1 g CELESTODERM-V
®
WITH GARAMYCIN
®
contains:
1.22 mg betamethasone valerate (Ph. Eur.) (equivalent to 1 mg of
betamethasone)
1.67 mg of gentamicin sulfate (equivalent to 1 mg of gentamicin)
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Cream
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATION(S)
Corticosteroid-responsive skin diseases in the presence of bacterial
superinfection for which
gentamicin is indicated.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology:
Unless otherwise prescribed, Cream is applied 2-3 times daily. The
frequency may be reduced as
the condition improves.
Method of administration:
A thin film of Cream should be applied to the affected areas of skin.
The method of administration should be adjusted to the skin type and
stage of the disease.
Cream is recommended in particular for greasy skin, weeping, itching,
burning and seborrhoic skin
diseases, in body folds, in acute stage.
Duration of use:
The duration of use of Cream should not exceed more than a couple of
days.
4.3
CONTRAINDICATIONS
Cream is contraindicated in those patients hypersensitive to the
active substances betamethasone
valerate, gentamicin sulfate, chlorocresol or to any of the excipients
listed in section 6.1 and in
patients hypersensitive to other corticosteroids or aminoglycoside
antibiotics.
Do not use in the presence of skin diseases caused primarily by
bacteria or viruses.
Cream is contraindicated in the presence of cutaneous tuberculosis and
viral infections.
Cream is not indicated for use on the eye or ear.
2
Because of the possibility of absorption of the active substance,
long-term treatment, application
on extensive areas of skin and/or treatment using occlusive dressings
should be avoided.
Do not use in patients with fungal diseases of the skin